Tag: Continuous Glucose Monitor (CGM)
In brief: CPAP’s adherence assumption, CGM’s benefits, Shaq’s sleep apnea
June 12, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
Study: CGM use lowers A1C in adults with Type 2 diabetes
June 11, 2026HME News Staff
NEW ORLEANS – Adults with Type 2 diabetes who are on of continuous glucose monitoring (CGM) but who are not on insulin saw substantially reduced hyperglycemia, resulting in a large reduction in A1C compared with a routine care control group, according to new researchers presented at the 2026 Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
The study found that CGM was associated with a substantial reduction in hyperglycemia, resulting in a 0.9% greater...
CGM: Make the box work harder
June 10, 2026Brett Siegal
Q. I’m already paying for CGM resupply shipments to go out every 30 or 90 days. Is there a way to make those boxes work harder for my business?
A. Yes – every box your distributor ships is a marketing opportunity most providers are leaving on the table.
Package inserts are the highest open-rate marketing method available to DME providers. (Almost) every shipment gets opened, providing a near-guaranteed marketing impression with every delivery. Some providers are not using package...
Medtronic’s MiniMed board sees shake up
May 19, 2026HME News Staff
NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy...
CGM: Avoid the leaky bucket
May 13, 2026Brett Siegal
Q. I'm adding CGM patients every month, but my overall program is not growing the way I'd expect. What am I missing?
A. Your program might have a leaky bucket.
It's one of the most common and costly problems in CGM resupply. Providers focus heavily on new patient acquisition, which is important, but if patients are quietly dropping off the back end, acquisition alone will not grow your resupply program at the rate you're expecting. You could be adding 50 new patients a month...
Senseonics launches Eversense 365 in Sweden, other countries to follow
April 27, 2026HME News Staff
GERMANTOWN, Md. – Senseonics Holdings has launched its Eversense 365 CGM system in Europe, following CE Mark approval in January. The Eversense 365 is now available to the first patients in Sweden, with launches to follow in Germany, Spain, and Italy during the coming weeks.The next-generation Eversense 365 doubles sensor lifespan from the previously available Eversense E3, from six months to a full year, and delivers key improvements such as reducing the frequency of calibrations from once...
CMS misses mark for CGMs, insulin pumps
April 24, 2026Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program overlooks how they are used and will not result in savings to the Medicare program, providers say.
Bundled CGM payments shift upfront costs and risk to suppliers
Currently, Medicare typically pays a one-time amount for CGM receivers, along with a monthly allowance for sensors, transmitters and other disposable supplies. Under the next round...
CGM use increases to one in six Medicare Advantage members, study finds
March 16, 2026HME News Staff
LOUISVILLE, Ky. – There was a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with Type 2 diabetes from 2021-23, according to a new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) and conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine.
The proportion of Medicare Advantage members with Type 2 diabetes who use insulin and CGMs increased from fewer...
Industry stakeholders seek changes to bid framework, enrollment moratorium
March 13, 2026Liz Beaulieu, Editor
WASHINGTON – Industry stakeholders hit Capitol Hill the week of March 9 for a series of high‑level meetings aimed at convincing the Centers for Medicare & Medicaid Services (CMS) to remove the remote‑item delivery (RID) framework from the next round of competitive bidding. They argue the agency has the authority to do so under its existing sub‑regulatory powers.
Stakeholders say CMS is using RID – which would require nationwide fulfillment capabilities – to shrink the pool...
Senators introduce bill to delay bidding for CGMs, insulin pumps
March 12, 2026HME News Staff
WASHINGTON – Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, have introduced a bill that would, among other things, delay Medicare competitive bidding for continuous glucose monitors (CGMs) and insulin pumps for five years.
The Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services Act (DIABETES Act), S. 4037, would also expand Medicare coverage of diabetes self-management training sessions, where diabetes educators help train Medicare patients...